{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:49:12Z","timestamp":1769834952803,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401874"],"award-info":[{"award-number":["81401874"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472346"],"award-info":[{"award-number":["81472346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602705"],"award-info":[{"award-number":["81602705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2016A020215105"],"award-info":[{"award-number":["2016A020215105"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2015A030313250"],"award-info":[{"award-number":["2015A030313250"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010226","name":"Educational Commission of Guangdong Province","doi-asserted-by":"crossref","award":["CXZD1120"],"award-info":[{"award-number":["CXZD1120"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation of President of The Traditional Chinese Medicine-integrated Hospital of Southern Medical University","award":["1201302009"],"award-info":[{"award-number":["1201302009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12943-017-0698-4","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T14:42:36Z","timestamp":1500302556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Feiye","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongcheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"698_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853\u20138.","journal-title":"Science"},{"key":"698_CR2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs\u2014microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259\u201369.","journal-title":"Nat Rev Cancer"},{"key":"698_CR3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","volume":"361","author":"J Ji","year":"2009","unstructured":"Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 2009;361:1437\u201347.","journal-title":"N Engl J Med"},{"key":"698_CR4","doi-asserted-by":"crossref","first-page":"e91827","DOI":"10.1371\/journal.pone.0091827","volume":"9","author":"J You","year":"2014","unstructured":"You J, Li Y, Fang N, Liu B, Zu L, Chang R, Li X, Zhou Q. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PLoS One. 2014;9:e91827.","journal-title":"PLoS One"},{"key":"698_CR5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3892\/ijo.2013.1963","volume":"43","author":"M Pacurari","year":"2013","unstructured":"Pacurari M, Addison JB, Bondalapati N, Wan YW, Luo D, Qian Y, Castranova V, Ivanov AV, Guo NL. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol. 2013;43:548\u201360.","journal-title":"Int J Oncol"},{"key":"698_CR6","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.febslet.2014.05.002","volume":"588","author":"Y Xia","year":"2014","unstructured":"Xia Y, Wu Y, Liu B, Wang P, Chen Y. Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC. FEBS Lett. 2014;588:2238\u201345.","journal-title":"FEBS Lett"},{"key":"698_CR7","first-page":"1692","volume":"2012","author":"B Liu","year":"1822","unstructured":"Liu B, Wu X, Wang C, Liu Y, Zhou Q, Xu K. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta. 1822;2012:1692\u2013704.","journal-title":"Biochim Biophys Acta"},{"key":"698_CR8","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1158\/0008-5472.CAN-13-2193","volume":"74","author":"Q Song","year":"2014","unstructured":"Song Q, Xu Y, Yang C, Chen Z, Jia C, Chen J, Zhang Y, Lai P, Fan X, Zhou X, et al. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM. Cancer Res. 2014;74:3031\u201342.","journal-title":"Cancer Res"},{"key":"698_CR9","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-09-0898","volume":"69","author":"SD Reddy","year":"2009","unstructured":"Reddy SD, Pakala SB, Ohshiro K, Rayala SK, Kumar R. MicroRNA-661, a c\/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. Cancer Res. 2009;69:5639\u201342.","journal-title":"Cancer Res"},{"key":"698_CR10","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1038\/onc.2010.181","volume":"29","author":"G Vetter","year":"2010","unstructured":"Vetter G, Saumet A, Moes M, Vallar L, Le Bechec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene. 2010;29:4436\u201348.","journal-title":"Oncogene"},{"key":"698_CR11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cdd.2013.146","volume":"21","author":"Y Hoffman","year":"2014","unstructured":"Hoffman Y, Bublik D, Pilpel Y, Oren M. miR-661 downregulates both Mdm2 and Mdm4 to activate p53. Cell Death Differ. 2014;21:302\u20139.","journal-title":"Cell Death Differ"},{"key":"698_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biopha.2015.07.023","volume":"75","author":"T Zhu","year":"2015","unstructured":"Zhu T, Yuan J, Wang Y, Gong C, Xie Y, Li H. MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression. Biomed Pharmacother. 2015;75:123\u20138.","journal-title":"Biomed Pharmacother"},{"key":"698_CR13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbrc.2015.11.046","volume":"468","author":"Z Li","year":"2015","unstructured":"Li Z, Liu YH, Diao HY, Ma J, Yao YL. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem Biophys Res Commun. 2015;468:870\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"698_CR14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/2159-8290.CD-14-0518","volume":"4","author":"PW Hinds","year":"2014","unstructured":"Hinds PW. A little pRB can lead to big problems. Cancer Discov. 2014;4:764\u20135.","journal-title":"Cancer Discov"},{"key":"698_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3567","volume":"14","author":"FA Dick","year":"2013","unstructured":"Dick FA, Rubin SM. Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol. 2013;14:297\u2013306.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"698_CR16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/B978-0-12-800249-0.00004-4","volume":"121","author":"C Schaal","year":"2014","unstructured":"Schaal C, Pillai S, Chellappan SP. The Rb-E2F transcriptional regulatory pathway in tumor angiogenesis and metastasis. Adv Cancer Res. 2014;121:147\u201382.","journal-title":"Adv Cancer Res"},{"key":"698_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ncb1532","volume":"9","author":"UK Binne","year":"2007","unstructured":"Binne UK, Classon MK, Dick FA, Wei W, Rape M, Kaelin WG Jr, Naar AM, Dyson NJ. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat Cell Biol. 2007;9:225\u201332.","journal-title":"Nat Cell Biol"},{"key":"698_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molcel.2004.09.029","volume":"16","author":"J Peng","year":"2004","unstructured":"Peng J, Jiang H, Rekhtman K, Bloom J, Ichetovkin M, Pagano M, Zhu L. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-Penetrance Rb mutant. Mol Cell. 2004;16:47\u201358.","journal-title":"Mol Cell"},{"key":"698_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng.498","volume":"42","author":"H Wang","year":"2010","unstructured":"Wang H, Bauzon F, Peng J, Xu X, Sun D, Locker J, Sellers RS, Nakayama K, Nakayama KI, Cobrinik D. Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+\/\u2212 mice. Nat Genet. 2010;42:83\u20138.","journal-title":"Nat Genet"},{"key":"698_CR20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ccm.2011.08.003","volume":"32","author":"JE Larsen","year":"2011","unstructured":"Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;32:703\u201340.","journal-title":"Clin Chest Med"},{"key":"698_CR21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J. Cancer Metastasis: building a framework. Cell. 2006;127:679\u201395.","journal-title":"Cell"},{"key":"698_CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1378\/chest.128.1.452","volume":"128","author":"P Yang","year":"2005","unstructured":"Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, Thibodeau S, Adjei AA, Jett J, Deschamps C. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest. 2005;128:452\u201362.","journal-title":"Chest"},{"key":"698_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lungcan.2011.11.013","volume":"76","author":"NT Tanner","year":"2012","unstructured":"Tanner NT, Pastis NJ, Sherman C, Simon GR, Lewin D, Silvestri GA. The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012;76:131\u20137.","journal-title":"Lung Cancer"},{"key":"698_CR24","doi-asserted-by":"crossref","unstructured":"Berge EM, Doebele RC: Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor. In Seminars in oncology Elsevier; 2014: 110-125. http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0093775413002169?via%3Dihub .","DOI":"10.1053\/j.seminoncol.2013.12.006"},{"key":"698_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275\u201392.","journal-title":"Cell"},{"key":"698_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B Craene De","year":"2013","unstructured":"De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13:97\u2013110.","journal-title":"Nat Rev Cancer"},{"key":"698_CR27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","volume":"101","author":"M Iwatsuki","year":"2010","unstructured":"Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101:293\u20139.","journal-title":"Cancer Sci"},{"key":"698_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265\u201373.","journal-title":"Nat Rev Cancer"},{"key":"698_CR29","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1073\/pnas.0807146105","volume":"105","author":"N Dumont","year":"2008","unstructured":"Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci U S A. 2008;105:14867\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"698_CR30","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1038\/srep08336","volume":"5","author":"R Bhajun","year":"2015","unstructured":"Bhajun R, Guyon L, Pitaval A, Sulpice E, Combe S, Obeid P, Haguet V, Ghorbel I, Lajaunie C, Gidrol X. A statistically inferred microRNA network identifies breast cancer target miR-940 as an actin cytoskeleton regulator. Sci Rep. 2015;5:8336.","journal-title":"Sci Rep"},{"key":"698_CR31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"698_CR32","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/jcp.24329","volume":"228","author":"R Fiore Di","year":"2013","unstructured":"Di Fiore R, D'Anneo A, Tesoriere G, Vento R. RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis. J Cell Physiol. 2013;228:1676\u201387.","journal-title":"J Cell Physiol"},{"key":"698_CR33","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/(SICI)1097-0215(19991222)84:6<604::AID-IJC11>3.0.CO;2-Y","volume":"84","author":"AM Hui","year":"1999","unstructured":"Hui AM, Li X, Makuuchi M, Takayama T, Kubota K. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer. 1999;84:604\u20138.","journal-title":"Int J Cancer"},{"issue":"37","key":"698_CR34","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1038\/onc.2016.32","volume":"35","author":"J Johnson","year":"2016","unstructured":"Johnson J, Thijssen B, McDermott U, Garnett M, Wessels LF, Bernards R. Targeting the RB-E2F pathway in breast cancer. Oncogene. 2016;35(37):4829\u201335.","journal-title":"Oncogene"},{"key":"698_CR35","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1158\/0008-5472.CAN-07-5680","volume":"68","author":"Y Arima","year":"2008","unstructured":"Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res. 2008;68:5104\u201312.","journal-title":"Cancer Res"},{"key":"698_CR36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature08677","volume":"462","author":"J-L Chong","year":"2009","unstructured":"Chong J-L, Wenzel PL, S\u00e1enz-Robles MT, Nair V, Ferrey A, Hagan JP, Gomez YM, Sharma N, Chen H-Z, Ouseph M. E2f1\u20133 switch from activators in progenitor cells to repressors in differentiating cells. Nature. 2009;462:930\u20134.","journal-title":"Nature"},{"key":"698_CR37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-14-0681","volume":"75","author":"S Pillai","year":"2015","unstructured":"Pillai S, Trevino J, Rawal B, Singh S, Kovacs M, Li X, Schell M, Haura E, Bepler G, Chellappan S. \u03b2-Arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial\u2013mesenchymal transition. Cancer Res. 2015;75:1009\u201320.","journal-title":"Cancer Res"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-017-0698-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:37:28Z","timestamp":1589769448000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-017-0698-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1186\/s12943-017-0698-4","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]},"article-number":"122"}}